Dr. Aly Karsan
Medical Director, Centre for Clinical Genomics, Genome Sciences Centre, BC Cancer Agency
Aly Karsan is Professor of Pathology and Laboratory Medicine, University of British Columbia, and Medical Director of the Cancer Genetics Laboratory, and Centre for Clinical Genomics in the Genome Sciences Centre, at the British Columbia Cancer Agency. He received his MD from Queen’s University at Kingston, completed his residency in Hematological Pathology at the University of British Columbia, followed by a research fellowship at the University of Washington in Seattle. Dr. Karsan’s clinical focus is to bring new genomic technologies into the diagnostic arena. His research interests focus on functional genomics in myeloid malignancies with a particular interest in the myelodysplastic syndromes (MDS). Recent research has revolved around the role of microRNAs and innate immune signaling pathways in MDS.
Aly Karsan is Professor of Pathology and Laboratory Medicine, University of British Columbia, and Medical Director of the Cancer Genetics Laboratory, and Centre for Clinical Genomics in the Genome Sciences Centre, at the British Columbia Cancer Agency. He received his MD from Queen’s University at Kingston, completed his residency in Hematological Pathology at the University of British Columbia, followed by a research fellowship at the University of Washington in Seattle. Dr. Karsan’s clinical focus is to bring new genomic technologies into the diagnostic arena. His research interests focus on functional genomics in myeloid malignancies with a particular interest in the myelodysplastic syndromes (MDS). Recent research has revolved around the role of microRNAs and innate immune signaling pathways in MDS.
